1. Larabi, Anaïs, Barnich, Nicolas, Nguyen, Hang Thi Thu. 2019. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. In Autophagy, 16, 38-51. doi:10.1080/15548627.2019.1635384. https://pubmed.ncbi.nlm.nih.gov/31286804/
2. Wang, Yan-Na, Gan, Ting, Qu, Shu, Zhou, Xu-Jie, Zhang, Hong. 2023. MTMR3 risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy. In Kidney international, 104, 562-576. doi:10.1016/j.kint.2023.06.018. https://pubmed.ncbi.nlm.nih.gov/37414396/
3. Zhou, Xu-Jie, Nath, Swapan K, Qi, Yuan-Yuan, Shen, Nan, Zhang, Hong. . Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy. In Arthritis & rheumatology (Hoboken, N.J.), 66, 2842-8. doi:10.1002/art.38749. https://pubmed.ncbi.nlm.nih.gov/24943867/
4. Hao, Feike, Itoh, Takashi, Morita, Eiji, Yoshimori, Tamotsu, Noda, Takeshi. 2015. The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity. In FEBS letters, 590, 161-73. doi:10.1002/1873-3468.12048. https://pubmed.ncbi.nlm.nih.gov/26787466/
5. Elhelaly, Mona, Shaker, Olfat G, Ayeldeen, Ghada, Elsergany, Alyaa R, Mostafa, Nora. 2023. Breast cancer risk is associated with the HULC rs7763881, MTMR3 rs12537 polymorphisms, and serum levels of HULC and MTMR3 in Egyptian patients. In Molecular biology reports, 50, 10073-10081. doi:10.1007/s11033-023-08897-1. https://pubmed.ncbi.nlm.nih.gov/37910386/
6. Lahiri, Amit, Hedl, Matija, Abraham, Clara. 2015. MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation. In Proceedings of the National Academy of Sciences of the United States of America, 112, 10461-6. doi:10.1073/pnas.1501752112. https://pubmed.ncbi.nlm.nih.gov/26240347/
7. Lin, Yong, Zhao, Jing, Wang, Hong, Cao, Jie, Nie, Yuqiang. 2017. miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3. In Molecular medicine reports, 15, 2451-2456. doi:10.3892/mmr.2017.6289. https://pubmed.ncbi.nlm.nih.gov/28447759/
8. Senousy, Mahmoud A, Helmy, Hebatullah S, Fathy, Nevine, Shaker, Olfat G, Ayeldeen, Ghada M. 2019. Association of MTMR3 rs12537 at miR-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in Egyptian patients. In Scientific reports, 9, 12299. doi:10.1038/s41598-019-48770-5. https://pubmed.ncbi.nlm.nih.gov/31444373/
9. Oppelt, Angela, Haugsten, Ellen M, Zech, Tobias, Skotheim, Rolf I, Wesche, Jørgen. . PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1. In The Biochemical journal, 461, 383-90. doi:10.1042/BJ20140132. https://pubmed.ncbi.nlm.nih.gov/24840251/
10. Wang, Zhan, Zhang, Min, Shan, Rong, Sun, Lun-Quan, Zhou, Wei-Bing. 2019. MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells. In Oncology reports, 42, 1915-1923. doi:10.3892/or.2019.7292. https://pubmed.ncbi.nlm.nih.gov/31485632/